Exploratory Study on Predicting CIDP Patients' Decline During IV Immunoglobulin Treatment Adaptation Feasibility.

ActiCIDP is a monocentric academic study. Patients with Chronic inflammatory demyelinating polyradiculoneuritis may be included on a voluntary basis. The investigators plan to include a group of approximately 40 patients with CIDP. The investigators have planned to assess patient every three months for a year. After each visit, participants will wear Actimyo for one month daily.

NCT Number	NCT06183645
Lead Sponsor	Centre Hospitalier Universitaire de Liege Collaborators: SYSNAV, Centre Hospitalier Régional de la Citadelle
Conditions	Chronic Inflammatory Demyelinating Polyneuropathy
Enrollment	40 participants
Start Date	2023-08-28
Primary Completion	2028-01 (estimated)
Study Completion	2028-01 (estimated)
Updated on ClinicalTrials.gov	2025-02-12